Experienced Leadership Team
Joseph (Jay) Hagan
President and Chief Executive Officer
-
Previously Mr. Hagan was President and Chief Executive Officer of Regulus Therapeutics from 2017 to 2025.
Cris Calsada
Chief Financial Officer
-
Previously, Ms. Calsada was Chief Financial Officer of Regulus Therapeutics from 2019 to 2025.
Gail Cawkwell, MD, PhD
Chief Medical Officer
-
Dr. Gail Cawkwell has nearly 25 years of pharmaceutical industry experience and has held prior CMO roles, most recently at Aclaris Therapeutics
Kunal Kishnani
SVP Corporate Development
-
Founder & CEO of Warden Bio (acquired by Kriya Therapeutics)
Jennifer Lam
SVP Finance and Administration
-
Dynamic and innovative finance professional with 15+ years advancement and achievement
Claire Padgett, PhD
SVP of Clinical Operations and Program Management
-
Previously, Dr. Padgett was SVP of Clinical Operations at Regulus Therapeutics from 2022 to 2025.
Board of Directors
Keith Katkin
Chairman of Ambros Therapeutics
Jay Hagan
Ambros Therapeutics Chief Executive Officer
Matthew Hammond, Ph.D.
RA Capital Management
Trit Garg, M.D.
Patient Square Capital
Prisca Di Martino
Abiogen Pharma
Investors
Loading...